Literature DB >> 33848831

A Novel Color-Coded Liver Metastasis Mouse Model to Distinguish Tumor and Adjacent Liver Segment.

Hiroto Nishino1, Hannah M Hollandsworth2, Siamak Amirfakhri2, Yoshihiko Tashiro3, Jun Yamamoto3, Michael A Turner2, Thinzar M Lwin2, Bernhard B Singer4, Robert M Hoffman5, Michael Bouvet6.   

Abstract

BACKGROUND: It is difficult to distinguish between a tumor and its liver segment with traditional use of indocyanine green (ICG) alone. In the present study, a method was used to limit ICG to the liver segment adjacent to a tumor. A spectrally-distinct fluorescently-labeled tumor-specific antibody against human carcinoembryonic antigen-related cell-adhesion molecules was used to label the metastatic tumor in a patient-derived orthotopic xenograft mouse model to enable color-coded visualization and distinction of a colon-cancer liver metastases and its adjacent liver segment.
MATERIALS AND METHODS: Nude mice received surgical orthotopic implantation in the liver of colon-cancer liver metastases derived from two patients. An anti- carcinoembryonic antigen-related cell-adhesion molecules monoclonal antibody (mAb 6G5j) was conjugated to a near-infrared dye IR700DX (6G5j-IR700DX). After three weeks, mice received 6G5j-IR700DX via tail-vein injection 48 hours before surgery. ICG was intravenously injected after ligation of the left or left lateral Glissonean pedicle resulting in labeling of the segment with preserved blood-flow in the liver. Imaging was performed with the Pearl Trilogy and FLARE Imaging Systems.
RESULTS: The metastatic liver tumor had a clear fluorescence signal due to selective tumor targeting by 6G5j-IR700DX, which was imaged on the 700 nm channel. The adjacent liver segment, with preserved blood-flow in the liver, had a clear fluorescence ICG 800 nm signal, while the left or left lateral segment had no fluorescence signal. Overlay of the images showed clear color-coded differentiation between the tumor fluorescing at 700 nm and the adjacent liver segment fluorescing at 800 nm.
CONCLUSIONS: Color-coding of a liver tumor and uninvolved liver segment has the potential for improved liver resection.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CEACAM; Colon cancer; Color-coded fluorescence imaging; Fluorescent tumor-specific antibody; Indocyanine green; Liver metastases; Nude mouse model

Mesh:

Substances:

Year:  2021        PMID: 33848831      PMCID: PMC8222089          DOI: 10.1016/j.jss.2021.02.022

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.417


  28 in total

1.  Prognostic impact of anatomic resection for hepatocellular carcinoma.

Authors:  Kiyoshi Hasegawa; Norihiro Kokudo; Hiroshi Imamura; Yutaka Matsuyama; Taku Aoki; Masami Minagawa; Keiji Sano; Yasuhiko Sugawara; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

2.  Real-time Navigation for Liver Surgery Using Projection Mapping With Indocyanine Green Fluorescence: Development of the Novel Medical Imaging Projection System.

Authors:  Hiroto Nishino; Etsuro Hatano; Satoru Seo; Takashi Nitta; Tomoyuki Saito; Masaaki Nakamura; Kayo Hattori; Muneo Takatani; Hiroaki Fuji; Kojiro Taura; Shinji Uemoto
Journal:  Ann Surg       Date:  2018-06       Impact factor: 12.969

3.  Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.

Authors:  Eric Suero Molina; Johannes Wölfer; Christian Ewelt; André Ehrhardt; Benjamin Brokinkel; Walter Stummer
Journal:  J Neurosurg       Date:  2017-03-24       Impact factor: 5.115

Review 4.  Indocyanine green fluorescence imaging in hepatobiliary surgery.

Authors:  Ali Majlesara; Mohammad Golriz; Mohammadreza Hafezi; Arash Saffari; Esther Stenau; Lena Maier-Hein; Beat P Müller-Stich; Arianeb Mehrabi
Journal:  Photodiagnosis Photodyn Ther       Date:  2016-12-23       Impact factor: 3.631

5.  Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts.

Authors:  Robert M Hoffman
Journal:  Nat Rev Cancer       Date:  2015-08       Impact factor: 60.716

6.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

7.  Applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy.

Authors:  Muga Terasawa; Takeaki Ishizawa; Yoshihiro Mise; Yosuke Inoue; Hiromichi Ito; Yu Takahashi; Akio Saiura
Journal:  Surg Endosc       Date:  2017-04-28       Impact factor: 4.584

Review 8.  Fluorescence-guided hepatobiliary surgery with long and short wavelength fluorophores.

Authors:  Thinzar M Lwin; Robert M Hoffman; Michael Bouvet
Journal:  Hepatobiliary Surg Nutr       Date:  2020-10       Impact factor: 7.293

9.  Hepatocyte Concentrations of Indocyanine Green Reflect Transfer Rates Across Membrane Transporters.

Authors:  Fabien Cusin; Liliana Fernandes Azevedo; Pierre Bonnaventure; Jules Desmeules; Youssef Daali; Catherine M Pastor
Journal:  Basic Clin Pharmacol Toxicol       Date:  2016-11-03       Impact factor: 4.080

10.  Real-time identification of liver cancers by using indocyanine green fluorescent imaging.

Authors:  Takeaki Ishizawa; Noriyoshi Fukushima; Junji Shibahara; Koichi Masuda; Sumihito Tamura; Taku Aoki; Kiyoshi Hasegawa; Yoshifumi Beck; Masashi Fukayama; Norihiro Kokudo
Journal:  Cancer       Date:  2009-06-01       Impact factor: 6.860

View more
  2 in total

1.  The Effect and Related Mechanism of Action of Astragalus Compatible with Curcumin against Colon Cancer Metastasis in Mice.

Authors:  Jiafei Wu; Decai Tang
Journal:  Gastroenterol Res Pract       Date:  2022-06-10       Impact factor: 1.919

Review 2.  Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible.

Authors:  Thinzar M Lwin; Michael A Turner; Siamak Amirfakhri; Hiroto Nishino; Robert M Hoffman; Michael Bouvet
Journal:  Cells       Date:  2022-01-12       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.